January 22, 2021 at 07:37PM Interacting with the FDA on Complex Innovative Trial Designs for Drugs and Biological Products

This the Guidance for Industry, Interacting with the FDA on Complex Innovative Trial Designs for Drugs and Biological Products, Level 1, CBER, CDER, Biologics, Drugs, December 2020

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2M6ENT4